Lewy Body Dementia Clinical Trials

A listing of Lewy Body Dementia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 67 clinical trials
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study

The purpose of the study is to evaluate the use of autologous Bone Marrow Derived Stem Cells (BMSC) as a means to improve cognitive impairment as occurs in Alzheimer's Disease and other dementias and to improve behavior and socialization issues which occur in adult Autism Spectrum Disorder. The use of …

alzheimer's disease
medical therapy
pervasive developmental disorder
cognitive impairment
  • 19 Sep, 2021
  • 7 locations
Accurate WiFi-Based Localization of Dementia Patients For Caregiver Support:

In this Phase II SBIR project we will enhance a wireless WiFi-based insole that was designed and successfully tested during a Phase I trial with elderly persons with dementia and their caregivers, and then investigate its efficacy in terms of caregiver activity, burden, and quality of life in Phase II. …

  • 14 Mar, 2021
  • 2 locations
A Study of CST-103 Co-administered With CST-107 in Subjects With Neurodegenerative Disorders

This is a Phase II, randomized, placebo-controlled, double-blind, crossover study on the CNS and pharmacodynamic effects of CST-103 co-administered with CST-107 in 4 subject populations with Neurodegenerative Disorders.

  • 28 Aug, 2021
  • 6 locations
Smell Voice and Nasal Swabs as Markers for Neuro-degenerative Disorders

Degenerative dementias including Alzheimer's Disease (AD), Parkinson's Disease with Dementia (PDD), Dementia with Lewy Bodies (DLB), Frontotemporal Dementias (FTLD), Corticobasal Degeneration

speech therapy
alzheimer's disease
degenerative disorders
cognitive impairment
mild cognitive impairment
  • 15 Apr, 2021
  • 1 location
Online Cognitive Rehabilitation of Executive Dysfunction in Nonamnestic MCI

, inhibition, and complex reasoning. Research shows that individuals with naMCI have an increased risk of developing non-Alzheimer's dementia such as frontotemporal dementia and dementia with Lewy bodies

executive dysfunction
alzheimer's disease
mild cognitive impairment
cognitive impairment
  • 25 Jan, 2021
  • 1 location
11C-PIB PET/CT in Patients With Parkinson's Disease and Parkinsonian Dementia Syndromes

To evaluate the potential contribution of amyloid burden, as indexed by 11C-Pittsburgh compound B (PiB) retention, to the progression of cognitive impairments in patients with Parkinson's disease(PD).

neurologic examination
cognitive impairment
movement disorder
  • 22 Jan, 2021
  • 3 locations
Source Monitoring D ficit in Neuropsychiatric Population

the investigators will measure source-monitoring ability in patients with several neuropsychiatric condition and in healthy controls appaired in age, sex and educational level. Source-monitoring will be measured thanks to internal- and reality-monitoring informatic tasks.The investigators hypothesized patients with fronto-temporal abnormalities would show more marked deficits than patients with only frontal …

  • 25 Jan, 2021
  • 1 location
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease

REM Behavior Sleep Disorder (RBD) is a sleep disorder causing people to 'act out' their dreams. A high percentage of individuals with idiopathic RBD (iRBD) are known to develop conditions affecting the neurons in the brain such as Parkinson's disease (PD). Based on the increased risk to develop PD, individuals …

sleep disorder
loss of smell
early parkinson's
  • 07 Aug, 2021
  • 1 location
Probiotics in Dementia

Dementia is associated with changes in gut microbiome composition, gut barrier dysfunction, intestinal inflammation and systemic inflammation. Probiotics are a possibility to modulate the gut-brain axis. In this study the effect of probiotics on the gut microbiome and, gut barrier function, inflammation and cognitive dysfunction will be studied.

  • 30 Jan, 2021
  • 1 location
Ambroxol as a Treatment for Parkinson's Disease Dementia

The present study will test the hypothesis that the medication Ambroxol is safe and well tolerated and will improve cognitive and motor symptoms of Parkinson's Disease Dementia (PDD). Ambroxol has been shown to raise the levels of the enzyme beta-glucocerebrosidase resulting in lower the levels of the protein alpha-synuclein, both …

  • 08 Feb, 2021
  • 1 location